Berkshire Hathaway Stock Has Gone Almost Nowhere in a Year. Should You Buy It Right Now?

Berkshire Hathaway's Q2 2026 operating earnings rose 16% year over year to roughly $13 billion, led by 24% growth in manufacturing, service and retail earnings and 27% growth at Berkshire Hathaway Energy, despite a 13% decline in insurance underwriting profit. The company became a net equity buyer for the first time in 14 quarters, purchasing about $39 billion of stocks versus $28 billion sold in H1, while deploying more than $16 billion on OxyChem and Taylor Morrison acquisitions. Berkshire also repurchased $4.5 billion of shares in Q2 at about $476-$488 per Class B share and retained $365 billion in cash and Treasury bills; Class B shares trade near $510.

Analysis

The investable change is not the earnings print but the capital-allocation regime: incremental deployment reduces the valuation discount historically assigned to an idle cash balance, provided acquisitions clear Berkshire’s cost of equity. The internal repurchase range is a useful valuation reference rather than a hard floor; at only a modest premium to recent purchases, downside appears better contained than for broad-market financial proxies over the next 1-3 months. A sustained buyback cadence would mechanically lift per-share intrinsic-value growth even if operating growth normalizes.

The weaker insurance contribution matters more than headline operating earnings imply. If underwriting pressure reflects competitive pricing rather than isolated claims volatility, float growth will become less valuable precisely as reinvestment yields decline; that would cap the earnings multiple and make the shares increasingly dependent on industrial, utility and rail execution over 6-18 months. New chemicals and housing exposure also increases sensitivity to construction demand, petrochemical spreads and credit availability, making Berkshire less purely defensive at the margin.

Berkshire’s reported Alphabet accumulation is strategically more relevant as a signal of willingness to take concentrated equity risk than as a reason to own GOOG. The market may be underpricing the possibility that a more active post-Buffett capital allocator narrows the cash drag, but it may also be overestimating how quickly a trillion-dollar platform can deploy capital at attractive returns. Confirmation should come from third-quarter buybacks, acquisition underwriting disclosures and the trajectory of insurance margins—not promotional commentary around book-value multiples.

Key Decisions for Investors

• Initiate a 6-12 month long BRK.B position on weakness toward the recent repurchase-price zone; target mid-single-digit downside versus 12-15% upside if recurring repurchases and redeployment support per-share value growth. Exit/reassess if buybacks again become de minimis while cash rises, or if insurance underwriting deterioration persists for two quarters.
• Use BRK.B as a quality-value substitute for part of an XLF allocation rather than a standalone financial beta trade: long BRK.B / short XLF over 3-6 months. The pair isolates diversified operating assets and capital allocation from bank credit-loss and deposit-beta risk; invalidate if long Treasury yields fall sharply and bank NIM expansion reaccelerates.
• Do not chase GOOG solely on Berkshire ownership disclosure. Maintain a watch item for evidence of a materially expanded stake in the next filing; absent that, GOOG’s risk/reward remains driven by AI monetization, capex intensity and regulatory outcomes rather than incremental Berkshire demand.
• Monitor housing and chemical indicators—existing-home sales, mortgage rates, U.S. housing starts and ethylene/caustic-soda spreads—before attributing acquisition-related earnings accretion to Berkshire. A broad housing slowdown or persistent chemical-margin compression would weaken the 6-18 month non-insurance earnings thesis.